Evaxion AS (EVAX)
3.29
-0.19
(-5.46%)
USD |
NASDAQ |
Feb 20, 16:00
3.30
+0.01
(+0.30%)
After-Hours: 20:00
Evaxion SG&A Expense (Quarterly) : 0.00 for March 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Novo Nordisk A/S | 2.718B |
| Ascendis Pharma A/S | 158.13M |
| DBV Technologies SA | 8.399M |
| Cellectis SA | 5.184M |
| Akari Therapeutics Plc | 1.963M |